Literature DB >> 20190812

CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.

M-Q Gao1, Y-P Choi, S Kang, J H Youn, N-H Cho.   

Abstract

Cancer stem cells (CSCs) have been identified in solid tumors and cancer cell lines. In this study, we isolated a series of cancer cell clones, which were heterogeneous in growth rate, cell cycle distribution and expression profile of genes and proteins, from ovarian tumor specimens of a patient and identified a sub-population enriched for ovarian CSCs defined by CD24 phenotype. Experiments in vitro demonstrated CD24(+) sub-population possessed stem cell-like characteristics of remaining quiescence and more chemoresistant compared with CD24(-) fraction, as well as a specific capacity for self-renewal and differentiation. In addition, injection of 5 x 10(3) CD24(+) cells was able to form tumor xenografts in nude mice, whereas equal number of CD24(-) cells remained nontumorigenic. We also found that CD24(+) cells expressed higher mRNA levels of some 'stemness' genes, including Nestin, beta-catenin, Bmi-1, Oct4, Oct3/4, Notch1 and Notch4 which were involved in modulating many functions of stem cells, and lower E-cadherin mRNA level than CD24(-) cells. Altogether, these observations suggest human ovarian tumor cells are organized as a hierarchy and CD24 demarcates an ovarian cancer-initiating cell population. These findings will have important clinical applications for developing effective therapeutic strategies to treat ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20190812     DOI: 10.1038/onc.2010.35

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  158 in total

1.  Isolation and characterization of stem-like cells from a human ovarian cancer cell line.

Authors:  Lijuan Wang; Roman Mezencev; Nathan J Bowen; Lilya V Matyunina; John F McDonald
Journal:  Mol Cell Biochem       Date:  2011-12-09       Impact factor: 3.396

2.  LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma.

Authors:  Wenjin Liu; Kimberly B Monahan; Adam D Pfefferle; Takeshi Shimamura; Jessica Sorrentino; Keefe T Chan; David W Roadcap; David W Ollila; Nancy E Thomas; Diego H Castrillon; C Ryan Miller; Charles M Perou; Kwok-Kin Wong; James E Bear; Norman E Sharpless
Journal:  Cancer Cell       Date:  2012-06-12       Impact factor: 31.743

Review 3.  The role of human aldehyde dehydrogenase in normal and cancer stem cells.

Authors:  Irene Ma; Alison L Allan
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

4.  Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.

Authors:  Ines A Silva; Shoumei Bai; Karen McLean; Kun Yang; Kent Griffith; Dafydd Thomas; Christophe Ginestier; Carolyn Johnston; Angela Kueck; R Kevin Reynolds; Max S Wicha; Ronald J Buckanovich
Journal:  Cancer Res       Date:  2011-04-15       Impact factor: 12.701

5.  Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.

Authors:  Adam D Steg; Ashwini A Katre; Blake Goodman; Hee-Dong Han; Alpa M Nick; Rebecca L Stone; Robert L Coleman; Ronald D Alvarez; Gabriel Lopez-Berestein; Anil K Sood; Charles N Landen
Journal:  Clin Cancer Res       Date:  2011-07-13       Impact factor: 12.531

6.  Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma.

Authors:  Hyun Goo Woo; Xin Wei Wang; Anuradha Budhu; Yun Hee Kim; So Mee Kwon; Zhao-You Tang; Zongtang Sun; Curtis C Harris; Snorri S Thorgeirsson
Journal:  Gastroenterology       Date:  2010-11-19       Impact factor: 22.682

Review 7.  Ovarian cancer stem cells: are they real and why are they important?

Authors:  Monjri M Shah; Charles N Landen
Journal:  Gynecol Oncol       Date:  2013-12-07       Impact factor: 5.482

8.  Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells.

Authors:  Y You; Y Li; M Li; M Lei; M Wu; Y Qu; Y Yuan; T Chen; H Jiang
Journal:  Clin Exp Immunol       Date:  2017-10-23       Impact factor: 4.330

9.  Artemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary carcinoma cells.

Authors:  Arindam Banerjee; PengXu Qian; Zheng-Sheng Wu; Xiaoge Ren; Michael Steiner; Nicola M Bougen; Suling Liu; Dong-Xu Liu; Tao Zhu; Peter E Lobie
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

10.  DOXIL when combined with Withaferin A (WFA) targets ALDH1 positive cancer stem cells in ovarian cancer.

Authors:  Sham S Kakar; Christopher A Worth; Zhenglong Wang; Kelsey Carter; Mariusz Ratajczak; Pranesh Gunjal
Journal:  J Cancer Stem Cell Res       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.